Related Experiment Video
Updated: Sep 14, 2026

Rapid Synthesis and Screening of Chemically Activated Transcription Factors with GFP-based Reporters
Published on: November 26, 2013
Anti-estrogen activity in the yeast transcription system: estrogen receptor mediated agonist response
H Kohno1, O Gandini, S W Curtis
1Receptor Biology Section, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709.
Abstract:
The mouse estrogen receptor was expressed in yeast cells to study the mechanism of action of anti-estrogens. Tamoxifen and hydroxytamoxifen, estrogen antagonists in mammalian tissues, failed to antagonize estradiol-induced expression of a VitA2-ERE-CTC1-lacZ reporter gene construct and exhibited full agonist activity, while nafoxidine exhibited partial antagonism as well as partial agonism. ICI 164,384 is a potent anti-estrogen in both mouse and human estrogen receptor systems. Our previous studies in the mouse uterus indicated that rapid degradation of the estrogen receptor accounted for the loss of estrogen responsiveness. In yeast however, ICI 164,384 or an isomer ICI 182,780 were unable to antagonize estradiol at concentration of 200 microM. On the contrary, both ICI compounds exhibited partial agonist activity by stimulating beta-galactosidase activity to 50% that of estradiol. We examined the level of estrogen receptor in the yeast after treatment with estradiol, ICI 164,384 or vehicle by Western blot and found no ICI-induced reduction of estrogen receptor levels, but observed an increase in estrogen receptor following estradiol treatment. This indicates that the proteolytic activity responsible for degrading estrogen receptor in ICI 164,384-treated uteri or eukaryotic cells is not present in yeast. The agonist activity seen with ICI indicated that ICI-bound estrogen receptor is able to induce expression of an estrogen-responsive reporter gene. In support of this, estrogen receptor from ICI 164,384-treated yeast was able to bind an estrogen-responsive element in a gel-shift assay.(ABSTRACT TRUNCATED AT 250 WORDS)
Insights
Yeast cells expressing mouse estrogen receptors showed tamoxifen and hydroxytamoxifen acting as agonists, not antagonists. ICI 164,384 also displayed partial agonist activity, unlike in mammalian systems, due to yeast lacking estrogen receptor degradation pathways.
Area of Science:
- * Molecular Endocrinology
- * Yeast Genetics
- * Drug Mechanism of Action
Background:
- * Estrogen receptors (ERs) mediate cellular responses to estradiol.
- * Anti-estrogens like tamoxifen and ICI 164,384 are crucial in hormone-dependent cancer therapy.
- * Previous studies suggested ER degradation contributes to anti-estrogen resistance in mammalian tissues.
Purpose of the Study:
- * To investigate the mechanism of anti-estrogen action using a yeast expression system.
- * To determine if yeast cells replicate the antagonistic effects of anti-estrogens observed in mammalian systems.
- * To explore the role of estrogen receptor stability in anti-estrogen response.
Main Methods:
- * Expression of mouse estrogen receptor in Saccharomyces cerevisiae.
- * Transfection with a VitA2-ERE-CTC1-lacZ reporter gene construct.
- * Treatment with estradiol, tamoxifen, hydroxytamoxifen, nafoxidine, and ICI 164,384.
- * Western blot analysis to assess estrogen receptor levels.
- * Gel-shift assay to evaluate estrogen-responsive element binding.
Main Results:
- * Tamoxifen and hydroxytamoxifen exhibited full agonist activity in yeast, contrary to their antagonist role in mammals.
- * ICI 164,384 and ICI 182,780 showed partial agonist activity, failing to antagonize estradiol.
- * Yeast cells lacked the proteolytic degradation of estrogen receptor observed in ICI 164,384-treated mammalian cells.
- * ICI-bound estrogen receptor demonstrated the ability to bind an estrogen-responsive element.
Conclusions:
- * Yeast cells provide a distinct model for studying estrogen receptor pharmacology, lacking mammalian-specific degradation pathways.
- * The agonist activity of ICI 164,384 in yeast suggests its bound receptor can activate transcription.
- * This study highlights the importance of cellular context, specifically protein stability, in determining anti-estrogen efficacy.
More Related Videos
Related Concept Videos
Yeast Signaling
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Diversity in Cell Signaling Responses
Graded and Abrupt Responses
Some signaling systems generate...
Signal Transduction: Overview
Typically, signal transduction involves three...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Stringent Response in E. coli

